AMERICAN SOCIETY FOR PERIPHERAL NERVE (EIN 431746236) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

MICHAEL NEUMEISTER MD

Phone

9789278330

Tax Period

2023-01-01 to 2023-12-31

AMERICAN SOCIETY FOR PERIPHERAL NERVE, founded in 1990, is a small nonprofit in the Medical Research sector that reported $358K in total revenue in fiscal year 2023. Revenue surged 41% from the prior year, signaling strong growth momentum. Expenses of $322K left a modest 10% surplus.

Mission

TO IMPROVE AND PROMOTE THE HIGHEST QUALITY OF CARE OF PATIENTS WITH NERVE DISORDERS THROUGH INTERDISCIPLINARY COLLABORATION, SCIENTIFIC INVESTIGATION, INNOVATION, AND EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $29,994

Program Service Revenue $313,270

Investment Income $13,659

Other Revenue $750

TOTAL REVENUE $357,673

Expense Breakdown

Grants Paid $9,530

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $277,288

Other Expenses $312,946

TOTAL EXPENSES $322,476

Year-over-Year Comparison

	2023	2022	Change
Revenue	$357,673	$254,431	+0.4%
Expenses	$322,476	$299,677	+0.1%
Net Income	$35,197	$-45,246	-1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL NEUMEISTER MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
JONATHAN WINOGRAD MD	PRESIDENT-EL	1.00	Officer Director	$0	$0	$0
IDA FOX MD	VICE PRESIDE	1.00	Officer Director	$0	$0	$0
AMY MOORE MD	SECRETARY/TR	1.00	Officer Director	$0	$0	$0
DOUG ROSS MD MED	TREASURER/HI	1.00	Officer Director	$0	$0	$0
SHAI ROZEN MD	HISTORIAN/SE	1.00	Officer Director	$0	$0	$0
GEDGE D ROSSON MD	PAST PRESIDE	1.00	Officer Director	$0	$0	$0
GREGORY H BORSCHEL MD	PAST PRESIDE	1.00	Officer Director	$0	$0	$0
THOMAS J WILSON MD	MEMBER-AT-LA	1.00	Director	$0	$0	$0
KRISTEN DAVIDGE MD	MEMBER-AT-LA	1.00	Director	$0	$0	$0
CHRISTOPHER DY MD MPH	MEMBER-AT-LA	1.00	Director	$0	$0	$0
JARET OLSON MD	MEMBER-AT-LA	1.00	Director	$0	$0	$0
ALISON K SNYDER-WARWICK MD	SYNAPSE EDIT	1.00	Director	$0	$0	$0
CHRISTINE NOVAK PT PHD	PAST PRES. (	1.00	Officer Director	$0	$0	$0
CATHERIN CURTIN MD	MEMBER (1/23	1.00	Director	$0	$0	$0
LINE G JACQUES MD MSC	MEMBER (1/23	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$357,673	$322,476	$698,128	$35,197
2022	$254,431	$299,677	$650,144	$-45,246
2021	$134,908	$86,511	$725,004	$48,397
2020	$275,501	$220,041	$519,681	$55,460
2019	$260,975	$224,343	$545,501	$36,632
2018	$244,132	$186,496	$406,490	$57,636

AMERICAN SOCIETY FOR PERIPHERAL NERVE